Temozolomide and Sorafenib in Treating Patients With Metastatic or Unresectable Melanoma
Clinical trial NCT00602576 · COMPLETED
Trial details
- NCT number
- NCT00602576
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-01-01
- Primary completion
- 2008-12-21
- Enrollment
- 169
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.